
On June 20, 2008, a meeting entitled zzso of new cancer treatments from canine to human cancer zzso sponsored by the National Cancer Institute in Bethesda, Maryland, was convened to discuss the potential value, opportunity, risks, and rewards of an integrated and comparative drug development path for new cancer zzso that includes naturally occurring zzso in pet zzso A summary of this meeting and subsequent discussion are provided here to afford clarity on the conduct of these studies so as to zzso the opportunities provided by this novel drug development and modeling zzso 

